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Abstract. The exogenously stimulated formation of intracellularly generated protoporphyrin IX, a
precursor of haem, is becoming one of the fastest developing areas in the field of photodynamic therapy (PDT).
We tested the action of several free radical scavengers, amino acids, antioxidants and sulphur-containing
compounds as protectors from photodamage induced by 5-aminolaevulinic acid (ALA)-mediated PDT, employ-
ing the LM2 cell line, derived from a mammary murine adenocarcinoma. We exposed the cells to di#erent
concentrations of the compounds, 24 h before PDT, during PDT, and 19 h after treatment. We defined the
protection grade (PG) as the ratio between cell survival after ALA-PDT treatment in the presence of the
protector and cell survival of ALA-PDT treatment alone. We found that -tryptophan (PG=9.2 at 2 m),
reduced glutathione (GSH) (PG=5.8 at 0.8 m), N-acetyl--cysteine (PG=4.86 at 30 m), melatonin (PG=4.5 at
8 m) and -methionine (PG=4.0 at 0.8 m) are the best protectors from PDT damage, followed by -cysteine
(PG=2.8 at 0.8 m), mannitol (PG=2.6 at 20 m) and glycine (PG=2.4 at 40 m) whereas oxidised glutathione
and S-adenosyl--methionine do not exert any protection. We did not found any photoactive action of the
protectors in absence of ALA. These results can be considered to modulate the photodamage induced by
ALA-PDT.
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INTRODUCTION
Photodynamic therapy (PDT) is a cancer
treatment modality that, through the admin-
istration of an exogenous tumour-localising
photosensitiser, mainly porphyrins, followed
by an adequate dose of photoactivating light
destroys malignant tissues [1]. New perspec-
tives have been opened by the use of the
porphyrin precursor 5-aminolaevulinic acid
(ALA), from which synthesis of the photo-
sensitiser protoporphyrin IX (PpIX), is
accomplished in situ [2,3].
The initial photodynamic e#ect is the light-
catalysed formation of active oxygen species,
notably singlet molecular oxygen (1O2) [4] by a
type II reaction and the generation of free
radicals and other reactive intermediates such
as hydroxyl radical (OH) and the superoxide
anion by a type I reaction [5]. The oxidation of
cellular constituents by these reactive oxygen
species (ROS) damages plasma membranes and
subcellular organelles.
Cellular protection mechanisms by way of
superoxide dismutase and the scavenger glu-
tathione avoided damage to organelles driven
by the phototoxic action of PpIX [6]. When the
scavengers trolox or -tocopherol succinate
were present during irradiation, the appear-
ance of apoptotic cells and cytotoxic e#ects in
murine leukaemia cells treated with photo-
sensitisers with lysosomal targets was pre-
vented [7]. Early apoptotic signals generated
by PDT were inhibited by the singlet oxygen
scavengers -histidine and -tocopherol, but
not by hydroxyl radical scavengers [8].
Porphyrin accumulation from ALA in epi-
dermal cells was decreased in the presence
of sodium azide or mannitol [9]. Mannitol is
a well-known hydroxyl radical scavenger,
whereas tryptophan, reduced glutathione
(GSH) and sodium azide, among others, are
antioxidants protecting organisms against
singlet oxygen.
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Glutathione has been shown to play a criti-
cal role in cellular defence against a variety of
injurious agents. Under normal steady-state
conditions, most of the glutathione exists in its
reduced form. Oxidation of GSH, either non-
enzymatically or by the action of glutathione
peroxidase, yields glutathione disulphide
(GSSG). NADPH-dependent reduction of
GSSG by glutathione reductase, as well as its
e%ux, e#ectively mantains the intracellular
concentration of GSH. Thus, in many cell
types, the glutathione oxidation–reduction
cycle helps to mantain structural and func-
tional viability in spite of endogenous pro-
duction of ROS overproduced during acute
oxidant injury.
Intracellular thiols may play a role in the
mechanisms of cancer treatment modalities
such as ionising radiation, chemotherapy and
hyperthermia [10]. A number of reports have
shown that resistance to chemotherapeutic
agents may be due to elevated cellular GSH
concentrations [11,12]. These studies have indi-
cated that GSH may be involved in protecting
cells via detoxification of cytotoxic species,
such as scavenging of free radicals and in the
repair of oxidative cellular damage by hydro-
gen donation. It has also been suggested that
GSH may influence DNA repair [13] as well as
help to mantain membrane integrity via the
formation of mixed disulphides [14]. GSH can
act against singlet oxygen and superoxide
anion radical [15]. Moreover, GSH depletion
sensitises cells to photodynamic damage [16].
S-adenosyl--methionine (SAM) is a precur-
sor of GSH which, unlike GSH itself, can
readily cross cell membranes. It has been
shown that supplementation of organ preser-
vation solutions with SAM instead of GSH has
improved hydroxyl radical and singlet oxygen
scavenging, as well as chelation of iron ions
[15].
Another sulphur-containing compound, N-
acetyl--cysteine (NAC), also increases GSH
levels by providing cysteine and it is known to
prevent pathologies elicited by free radicals
and ROS [17]. Tao et al. [18] found that
NAC significantly overcame the e#ect on
PDT-induced stress-activated protein kinase.
It was also found that NAC protected against
apoptosis mediated by pyropheophorbide-a-
methylester in colon cancer cells [19]. How-
ever, NAC failed to attenuate PpIX-induced
photosensitivy in erythropoietic protoporphy-
ria [20] and patients treated with Photofrin
[21].
In addition, the non-sulphur amino acid gly-
cine, was shown to protect human endothelial
cells from H2O2-induced lethal injury and also
to diminish radiation-induced cytotoxicity in
bovine endothelial cells [22,23].
The aim of this work was to evaluate the
protector action of some free radical scaven-
gers, amino acids, antioxidants and sulphur-
containing compounds against the cytotoxic
photodynamic action of ALA-PDT.
MATERIALS AND METHODS
Chemicals
ALA, -cysteine, -trypthophan, -methionine,
glycine, mannitol, melatonin,
S-adenosylmethionine (SAM), N-acetyl--
cysteine (NAC), reduced glutathione (GSH)
and oxidised glutathione (GSSG) were
obtained from Sigma Chem Co.
Cell Line and Cell Culture
Cell line LM2 [24] derived from murine
mammary adenocarcinoma M2 (Instituto
Ro#o, Buenos Aires) was cultured in minimum
essential Eagle’s medium (MEM), supple-
mented with 2 m -glutamine, 40 g
gentamycin/ml and 5% fetal bovine serum
(FBS), and incubated at 37C in an atmosphere
containing 5% CO2.
ALA-PDT Treatment
Cells (3.5104 per well) were incubated in
serum-free medium containing 0.2 m ALA in
24-well plates, and 3 h later, laser irradiations
were performed. After 5 min of irradiation,
medium was replaced by ALA-free
medium+fetal bovine serum, cells were incu-
bated for another 19 h and then tested for
viability. Irradiations were performed using a
rhodamine dye laser (Model DL30, Oxford
Lasers) pumped by a copper vapour laser
(CU15A, Oxford Lasers) tuned to 630 nm. The
light was focused into a 400 m-diameter opti-
cal fibre coupled to a frontal light distributor
(Model FD2, Medlight, Ecublens, Switzerland)
to produce a treatment area of uniform inten-
sity. The output power from the fibre was
measured with a power meter (Model
LM-100XL, Coherent, Auburn, CA) before each
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application, and adjusted to the desired light
dose (4.6 J/cm2). Non-ALA and non-irradiated
controls were also run.
Drug Exposure
The scavengers, amino acids, antioxidants and
sulphur-containing compounds were dissolved
in sterile Earle’s salts, pH 7.4 and added to
the cells 24 h before PDT. They were also
present during the 3-h exposure to ALA, dur-
ing the 5 min of laser irradiation and 19 h after
treatment.
MTT Viability Assay
Phototoxicity/toxicity was documented by the
MTT assay [25], a method based on the activity
of mitochondrial dehydrogenases, which
will be functionally a#ected by PDT in vitro
[26]. At 19 h after treatments, MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide) solution was added to each well at a
concentration of 0.5 mg/ml, and plates were
incubated at 37C for 1 h. The resulting forma-
zan crystals were dissolved by the addition of
dimethylsulphoxide (DMSO) and absorbance
was read at 560 nm.
Cell Number
The number of cells seeded per well was deter-
mined by counting viable cells with the Trypan
blue exclusion method.
RESULTS
Effect of Protectors on Cell Survival induced
by ALA-PDT, ALA and Light Exposure
Figures 1–4 show the action of some free
radical scavengers, amino acids, antioxidants
and sulphur-containing compounds on cell
viability under four di#erent experimental
conditions: the impact of the protector itself on
cell viability, the potential photoactive action
of the compound when illuminated, the cyto-
toxic action of the compound when coincu-
bated with ALA and the e#ect of the compound
in modifying ALA-PDT induced cytotoxicity.
ALA concentration and time exposure as
well as light conditions were determined in
previous work [27].
None of the compounds were cytotoxic by
themselves at low concentrations, however,
they decreased cell viability by more than 20%
at higher and di#erent concentrations for each
compound: SAM 0.02 m, melatonin and
cysteine 3 m, glycine and methionine 4 m,
GSSG 15 m and NAC, tryptophan, GSH and
mannitol 20 m.
We did not find any photoactive action of the
protectors by themselves. When the com-
pounds were coincubated with ALA in the
absence of light, in most cases there was a
general reversion of the dark toxicity induced
by ALA. The exception was GSSG, that
enhanced ALA-induced cytotoxicity. As a
Fig. 1. Effects of SAM, GSH and methionine on cell survival
induced by PDT, ALA and light exposure. Tryptophan and
mannitol were added to the cells from 24 h before PDT to
19 h after treatment, ALA and light exposure period included.
PDT-treated cells (), ALA-treated cells (), light-irradiated
cells () and untreated control cells (). MTT assay was
performed after replacing the medium with free-scavenger
medium. The percentage of survival was referred to control
cells neither PDT-treated nor exposed to scavengers. Each
data point represents the average of three determinations.
Error bars show standard deviations.
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general pattern, the concentrations a#ording
protection against ALA-induced cytotoxicity
were coincident with the concentrations pro-
tecting against PDT. The e#ect of these protec-
tors on the cytoxicity induced by ALA-PDT
compared to the behaviour of PDT-treated
cells in their absence, is further examined in
Figs 5 and 6.
Influence of Protectors on Cell Survival after
ALA-PDT
To study the e#ect of the free radicals
scavengers, amino acids, antioxidants and
sulphur-containing compounds comparatively,
we defined the protection grade (PG) as the
ratio between cell survival after ALA-PDT
treatment in the presence of the di#erent com-
pounds and cell survival without protectors.
Maximum protection grades were found at
varying concentrations depending on the com-
pound. -Tryptophan (PG=9.2 at 2 m), GSH
(PG=5.8 at 0.8 m), NAC (PG= 5.3 at 20 m),
melatonin (PG=4.5 at 8 m) and -methionine
(PG=4.0 at 0.8 m) were found to be the
best protectors from PDT damage at their
optimal concentrations, followed by -cysteine
(PG=2.8 at 0.8 m), mannitol (PG=2.6 at
20 m) and glycine (PG=2.4 at 40 m). Oxi-
dised glutathione and S-adenosyl--methionine
did not exert any protection.
In a parallel set of experiments, cells were
exposed to protectors, prior to PDT, during
PDT, and after PDT separately, and in a com-
bination of these experimental conditions. We
found that the maxima PGs were reached when
cells were treated with the protector before
and during PDT; its addition after PDT did not
improve cell survival (data not depicted).
DISCUSSION
-Tryptophan, a well-known and e$cient
singlet oxygen quencher (Table 1), was the best
protector among all the compounds assayed,
a#ording a PG of 9.2 at a concentration as low
Fig. 2. Effects of tryptophan and mannitol on cell survival
induced by PDT, ALA and light exposure. SAM, GSH and
methionine were added to the cells from 24 h before PDT to
19 h after treatment, ALA and light exposure period included.
PDT-treated cells (), ALA-treated cells (), light-irradiated
cells () and untreated control cells (). MTT assay was
performed after replacing the medium with free-scavenger
medium. The percentage of survival was referred to control
cells neither PDT-treated nor exposed to scavengers. Each
data point represents the average of three determinations.
Error bars show standard deviations.
Fig. 3. Effects of melatonin and glycine on cell survival
induced by PDT, ALA and light exposure. NAC, cysteine and
GSSG were added to the cells 24 h before PDT, during ALA
and light exposure period and 19 h after treatment. PDT-
treated cells (), ALA-treated cells (), light-irradiated
cells () and untreated control cells (). MTT assay was
performed after replacing the medium with free-scavenger
medium. The percentage of survival was referred to control
cells neither PDT-treated nor exposed to scavengers. Each
data point represents the average of three determinations.
Error bars show standard deviations.
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as 2 m. On the other hand, the hydroxyl
radical scavenger mannitol a#orded little pro-
tection (PG=2.6 at 20 m). Although lack of
specificity of free radical quenching should
be considered, these findings may underline
the predominant role of 1O2 in ALA-PDT cell
killing.
Regarding the sulphur-containing com-
pounds, GSH was highly protective. The essen-
tial amino acid methionine can be converted
into SAM, which through a series of tran-
sulphuration reactions yields cysteine and
from cysteine comes GSH. The aminothiol
NAC can scavenge free radicals through bind-
ing of the reduced sulphydryl group, either by
thiol metabolism or by enhancing GSH
metabolism. NAC itself can act as a singlet
oxygen quencher. In vivo, NAC forms cysteine,
cystine, methionine, glutathione and mixed
sulphides [28].
In this study GSH (PG=5.8 at 0.8 m), NAC
(PG=5.3 at 20 m) and methionine (PG=4.0 at
0.8 m), when used at their maximal protection
concentrations, a#orded higher protection
against ALA-PDT damage than -cysteine
(PG=2.8 at 0.8 m), which a#orded only a
slight protection. However it should be noted
that much higher NAC concentration is
needed to induce the same e#ect as that
produced by GSH. Although for most of the
compounds maxima protection grades were
reached at relatively high concentrations, it
has to be taken into account that concen-
trations above 1 m are not pharmacologically
relevant.
Unexpectedly, SAM did not show any pro-
tection against ALA-PDT, perhaps because at
the concentrations tested, higher than 0.02 m,
it appears to have some toxic e#ect. As
Fig. 4. Effects of NAC, cysteine and GSSG on cell survival
induced by PDT, ALA and light exposure. Melatonin and
glycine were added to the cells 24 h before PDT, during ALA
and light exposure period and 19 h after treatment. PDT-
treated cells (), ALA-treated cells (), light-irradiated cells
() and untreated control cells (). MTT assay was per-
formed after replacing the medium with free-scavenger
medium. The percentage of survival was referred to control
cells neither PDT-treated nor exposed to scavengers. Each
data point represents the average of three determinations.
Error bars show standard deviations.
Fig. 5. Influence of protectors on cell survival after ALA-
PDT. SAM, GSH, methionine, tryptophan and mannitol were
added to the cells 24 h before PDT, during ALA and light
exposure period and 19 h after treatment. MTT assay was
performed after replacing the medium with free-scavenger
medium. PG is the ratio between cell survival after ALA-PDT
treatment in the presence of the different compounds and cell
survival without protectors.
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expected, the oxidised form of glutathione,
GSSG, neither protected nor enhanced
PDT-induced photoxicity.
Cell viability of both non-treated controls
and ALA-PDT-treated cells increased 60% in
the presence of GSH, showing an unspecific
cell metabolism activation. On the other hand,
tryptophan increases 40% non-treated cells
viability but a much higher increase (140%) is
observed in PDT treated cells, demonstrat-
ing in addition, a specific protection against
photodamage.
The pineal hormone melatonin is a potent
hydroxyl radical scavenger [29]. Additionally,
melatonin has been reported to neutralise
hydrogen peroxide, singlet oxygen, peroxy-
nitrite anion and nitric oxide, and it also
stimulates several antioxidative enzymes [30].
In our study we proved that this hormone is an
excellent protector (PG=4.5 at 8 m), at nearly
the same level as the the sulphur-containing
compounds NAC and methionine.
In addition to singlet oxygen, which is the
primary cytotoxic agent in PDT, other inter-
convertible reactive oxygen species, in particu-
lar OH [31] are also generated. Moreover, 1O2,
which is a powerful active oxygen form but not
a free radical, may induce the formation of
oxygen free radicals [32,33]. These two facts
explain the ability of the radical scavengers to
protect from ALA-PDT-induced damage.
The protection exerted by the non-sulphur
amino acid tryptophan is probably due to
quenching of 1O2 to photooxidation [31] and
the slight action of glycine may be ascribed to
direct oxidation of the molecule [21]. In agree-
ment with our results, Henderson and Miller
[31] found that tryptophan largely abolished
PDT cell damage induced by Photofrin in CHO
Fig. 6. Influence of protectors on cell survival after ALA-
PDT. Glycine, melatonin, NAC, cysteine and GSSG were
added to the cells 24 h before PDT, during ALA and light
exposure period and 19 h after treatment. MTT assay was
performed after replacing the medium with free-scavenger
medium. PG is the ratio between cell survival after ALA-PDT
treatment in the presence of the different compounds and cell
survival without protectors.






SAM Precursor of GSH. Can Cross cell membranes No protection
NAC Scavenge by thiol metabolism or enhancing GSH metabolism. 1O2 quencher Protective
GSH Scavenger of free radicals. Hydrogen donation Protective
Cysteine Precursor of GSH Slight protection
GSSG Product of GSH oxidation. No protective action No protection
Methionine Precursor of GSH Protective
Tryptophan Mainly 1O2 quencher Best protection
Mannitol Mainly OH scavenger Slight protection
Glycine Oxidation helps to maintain cellular redox state Slight protection
Melatonin Mainly OH but also scavenger of many free radicals Protective
SAM, S-adenosylmethionine; NAC, N-acetylcysteine; GSH, reduced glutathione; GSSG, oxidised glutathione.
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cells. Glycine was found to protect against
ionising radiation [21], but there were no
reports on protection against PDT.
Maximum PGs were found when the cells
were protected before and during PDT,
whereas protection after PDT did not improve
cell survival. In contrast to our results,
addition of the radical scavengers trolox or
-tocopherol during the 60 min after
irradiation of photosensitised murine leu-
kaemia cells with tin etiopurpurin, a#orded
partial protection from apoptosis and photo-
toxicity [7]. However, the lysosomal localis-
ation of the photosensitiser may induce
long-persisting photoproducts, which may not
occur with PpIX formed from ALA, which
localises mainly in mitochondria.
In conclusion, our results concerning cell
survival following PDT in the presence of
various agents a#ecting cytotoxic molecular
species show that -tryptophan, an e$cient
singlet oxygen quencher is the best protector
from PDT damage, followed by the sulphur-
containing compounds GSH, NAC and
methionine, and the hormone melatonin. The
presence of the protectors before and during
laser illumination is crucial for protection.
These findings are useful in the design of a
phototherapeutic strategy imparting better
protection for normal tissue against the
undesirable e#ects of PDT.
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C.P. is a ‘Carrillo-Oñativia’ fellow from the Ministerio de
Salud Pública.
REFERENCES
1. Dougherty T. Photodynamic therapy (PDT) of malig-
nant tumors. Crit Rev Oncol Hematol 1984;2:83–116.
2. Kennedy J, Pottier R, Pross G. Photodynamic therapy
with endogenous protoporphyrin IX: basic principles
and present clinical experience. J Photochem Photo-
biol B 1990;6:143–8.
3. Fukuda H, Casas A, Chueke F, Paredes S, Batlle A.
Photodynamic action of endogenously synthesized por-
phyrins from aminolevulinic acid, using a new model
for assaying the e#ectiveness of tumoral cell killing.
Int J Biochem 1993;25:1395–8.
4. Weishaupt K, Gomer C, Dougherty T. Identification of
singlet oxygen as cytotoxic agent in photoinactivation
of murine tumor. Cancer Res 1976;36:2326–9.
5. Bonnett R, Lambert C, Land E, Scourides P, Sinclair
R, Truscott T. The triplet and radical species of
hematoporphyrin and some of its derivatives.
Photochem Photobiol 1983;38:1–8.
6. Van Graft M, Boot J. Photodynamic e#ects of pro-
toporphyrin on the cellular level – an in vitro
approach. In vitro Cell Dev Biol Anim 1996;32:394–8.
7. Kessel D, Luo Y. Delayed oxidative photodamage
induced by photodynamic therapy. Photochem
Photobiol 1996;64:601–4.
8. Chan W, Yu J, Yang S. Apoptotic signalling cascade in
photosensitized human epidermal carcinoma A431
cells: involvement of singlet oxygen, c-jun N-terminal
kinase, caspase-3 and p21-activated kinase 2. Biochem
J 2000;351:221–32.
9. He D, Behar S, Nomura N, Sassa S, Taketani S, Lim H.
The e#ect of porphyrin and radiation on ferrochelatase
and 5-aminolevulinic acid synthase in epidermal
cells. Photodermatol Photoimmunol Photomed 1995;11:
25–9.
10. Arrick B, Nathan C. Glutathione metabolism as a
determinant of therapeutic e$cacy: a review. Cancer
Res 1984;44:4224–32.
11. Richardson M, Siemann D. DNA damage in
cycloposphamide-resistant tumor cells: the role of
glutathione. Cancer Res 1995;55:1691–5.
12. Siemann D, Beyers K. In vivo therapeutic potential
of combination thiol depletion and alkylating
chemotherapy. Br J Cancer 1993;68:1071–9.
13. Revesz M, Larsson A. Induction and repair of single-
strand DNA breaks after X-ray irradiation of human
fibroblasts deficient in glutathione. Int J Radiat Biol
1981;40:355–63.
14. Isaacs J, Binkley F. Glutathione dependent control of
protein disulfide-sulfhydryl content by subcellular
fractions of hepatic tissue. Biochim Biophys Acta
1979;497:192–204.
15. Evans P, Whiteman M, Tredger M, Halliwell B. Anti-
oxidant properties of S-adenosyl-L-methionine: a pro-
posed addition to organ storage fluids. Free Rad Biol
Med 1997;23:1002–8.
16. Miller A, Henderson B. The influence of cellular
glutathione content on cell survival following photo-
dynamic treatment in vitro. Radiat Res 1986;107:83–94.
17. Patterson C, Butler J, Byrne F, Rhodes M. Oxydant
lung injury intervention with sulphydryl reagents.
Lung 1986;163:23–32.
18. Tao J, Jasbinder S, Pelech S, Wong G, Levy J. Stimu-
lation of stress-activated protein kinase and p38 HOG1
kinase in murine keratinocytes following photody-
namic therapy with benzoporphyrin derivative. J Biol
Chem 1996;271:27107–15.
19. Matroule J, Carthy C, Granville D, Jolois O, Hunt D,
Piette J. Mechanism of colon cancer cell apoptosis
mediated by pyropheophorbide-a methylester photo-
sensitization. Oncogene 2001;20:4070–84.
20. Bijlmer-Iest J, Baarte de la Faille H, van Asbeck B,
van Hattum J, van Weelden H, Marx J et al. Protopor-
phyrin photosensitivity cannot be attenuated by
oral N-acetylcysteine. Photodermatol Photoimmunol
Photomed 1992;9:245–9.
228 C. Perotti et al.
21. Baas P, van Mamsom I, van Tinteven H, Stewart F,
van Zandwijk N. E#ect pf N-acetylcysteine on Photo-
frin induced skin photosensitivity in patients. Lasers
Surg Med 1995;16:359–67.
22. Weinberg J, Varani J, Johnson K, Roeser N, Dame N,
Davis J et al. Protection of human umbilical vein
endothelial cells by glycine and structurally similar
aminoacids against calcium and hydrogen peroxide
induced lethal cell injury. Am J Pathol 1992;140:
457–71.
23. Ts’ao C, Molteni A, Taylor J. Injury-specific cytotoxic
response of tumor cells and endothelial cells. Pathol
Res Pract 1996;192:1–9.
24. Galli S, Colombo L, Vanzuli S, Daroqui M, Vidal M,
Jasnis A et al. Characterization of a fibroblastoid
mammary carcinoma cell line (LM2) originated from a
mouse adenocarcinoma. Int J Oncol 2000;17:1259–65.
25. Denizot F, Lang R. Rapid colorimetric assay for cell
growth and survival. Modifications to the tetrazolium
dye procedure giving improved sensitivity and
reliability, J Immunol Methods 1986;89:271–7.
26. Hilf R, Smail D, Murant R, Leakey P, Gibson S.
Hematoporphyrin derivative induced photosensitivity
of mitochondrial succinate dehydrogenase and
selected cytosolic enzymes of R3230AC mammary
adenocarcinomas of rats. Cancer Res. 1984;44: 1483–8.
27. Casas A, Fukuda H, Di Venosa G, Batlle A. Photosen-
sitisation and mechanism of cytotoxicity induced by
the use of ALA derivatives in photodynamic therapy.
Br J. Cancer 2001;85:279–84.
28. Baas P, Oppelaar H, van der Valk M, van Zandwijk N,
Stewart F. Partial protection of photodynamic-induced
skin reactions in mice by N-acetylcysteine: a pre-
clinical study. Photochem Photobiol 1994;59:448–54.
29. Reiter R, Tan D, Poeggeler B, Chen L, Menendez-
Pelaez A. Melatonin, free radicals and cancer initia-
tion. In: Maestroni G, Conti A, Reitter R (eds)
Advances in Pineal Research, Vol. 7. John Libbey,
1994;211–28.
30. Reiter R, Tsan D, Osuna C, Gitto E. Actions of
melatonin in the reduction of oxidative stress: a
review. J Biomed Sci 2000;7:444–58.
31. Henderson B, Miller A. E#ects of scavengers of
reactive oxygen and radical species on cell survival
following photodynamic treatment in vitro: com-
parison with ionizing radiation. Radiat Res 1986;108:
196–205.
32. Hideg E, Spetea C, Vass I. Singlet oxygen and free
radical production during acceptor- and donor-side-
induced photoinhibition. Studies with spin trapping
EPR spectroscopy. Biochim Biophys Acta 1994;1186:
143–52.
33. Buettner G.Thiyl free radical production with
hematoporphyrin derivative, cysteine and light: a
spin-trapping study. FEBS 1984;177:295–9.
Paper received 24 October 2001;
accepted after revision 5 May 2002.
Protection against Photodynamic Therapy 229
